vs

Side-by-side financial comparison of JFrog Ltd (FROG) and HARROW, INC. (HROW). Click either name above to swap in a different company.

JFrog Ltd is the larger business by last-quarter revenue ($145.3M vs $89.1M, roughly 1.6× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -10.5%, a 17.9% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 25.2%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 20.4%).

JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

FROG vs HROW — Head-to-Head

Bigger by revenue
FROG
FROG
1.6× larger
FROG
$145.3M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+8.1% gap
HROW
33.3%
25.2%
FROG
Higher net margin
HROW
HROW
17.9% more per $
HROW
7.4%
-10.5%
FROG
More free cash flow
FROG
FROG
$41.8M more FCF
FROG
$49.9M
$8.1M
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
20.4%
FROG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FROG
FROG
HROW
HROW
Revenue
$145.3M
$89.1M
Net Profit
$-15.2M
$6.6M
Gross Margin
77.9%
79.3%
Operating Margin
-14.7%
17.5%
Net Margin
-10.5%
7.4%
Revenue YoY
25.2%
33.3%
Net Profit YoY
34.4%
-2.2%
EPS (diluted)
$-0.13
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FROG
FROG
HROW
HROW
Q4 25
$145.3M
$89.1M
Q3 25
$136.9M
$71.6M
Q2 25
$127.2M
$63.7M
Q1 25
$122.4M
$47.8M
Q4 24
$116.1M
$66.8M
Q3 24
$109.1M
$49.3M
Q2 24
$103.0M
$48.9M
Q1 24
$100.3M
$34.6M
Net Profit
FROG
FROG
HROW
HROW
Q4 25
$-15.2M
$6.6M
Q3 25
$-16.4M
$1.0M
Q2 25
$-21.7M
$5.0M
Q1 25
$-18.5M
$-17.8M
Q4 24
$-23.2M
$6.8M
Q3 24
$-22.9M
$-4.2M
Q2 24
$-14.3M
$-6.5M
Q1 24
$-8.8M
$-13.6M
Gross Margin
FROG
FROG
HROW
HROW
Q4 25
77.9%
79.3%
Q3 25
77.4%
75.3%
Q2 25
76.3%
74.5%
Q1 25
75.3%
67.5%
Q4 24
75.4%
78.8%
Q3 24
75.0%
75.6%
Q2 24
78.8%
74.4%
Q1 24
79.5%
69.5%
Operating Margin
FROG
FROG
HROW
HROW
Q4 25
-14.7%
17.5%
Q3 25
-15.8%
20.6%
Q2 25
-20.4%
17.9%
Q1 25
-18.8%
-23.5%
Q4 24
-21.9%
19.3%
Q3 24
-27.4%
2.7%
Q2 24
-18.6%
3.1%
Q1 24
-16.6%
-20.0%
Net Margin
FROG
FROG
HROW
HROW
Q4 25
-10.5%
7.4%
Q3 25
-12.0%
1.4%
Q2 25
-17.0%
7.8%
Q1 25
-15.1%
-37.2%
Q4 24
-20.0%
10.1%
Q3 24
-21.0%
-8.6%
Q2 24
-13.9%
-13.2%
Q1 24
-8.8%
-39.2%
EPS (diluted)
FROG
FROG
HROW
HROW
Q4 25
$-0.13
$0.20
Q3 25
$-0.14
$0.03
Q2 25
$-0.19
$0.13
Q1 25
$-0.16
$-0.50
Q4 24
$-0.21
$0.19
Q3 24
$-0.21
$-0.12
Q2 24
$-0.13
$-0.18
Q1 24
$-0.08
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FROG
FROG
HROW
HROW
Cash + ST InvestmentsLiquidity on hand
$704.4M
$72.9M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$887.4M
$52.4M
Total Assets
$1.3B
$399.5M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FROG
FROG
HROW
HROW
Q4 25
$704.4M
$72.9M
Q3 25
$651.1M
$74.3M
Q2 25
$611.7M
$53.0M
Q1 25
$563.5M
$66.7M
Q4 24
$522.0M
$47.2M
Q3 24
$467.8M
$72.6M
Q2 24
$591.3M
$71.0M
Q1 24
$579.6M
$76.0M
Total Debt
FROG
FROG
HROW
HROW
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
FROG
FROG
HROW
HROW
Q4 25
$887.4M
$52.4M
Q3 25
$859.4M
$47.0M
Q2 25
$826.5M
$49.7M
Q1 25
$800.0M
$56.5M
Q4 24
$773.5M
$69.7M
Q3 24
$756.2M
$58.0M
Q2 24
$721.4M
$58.5M
Q1 24
$707.8M
$60.6M
Total Assets
FROG
FROG
HROW
HROW
Q4 25
$1.3B
$399.5M
Q3 25
$1.3B
$363.1M
Q2 25
$1.2B
$345.0M
Q1 25
$1.2B
$364.2M
Q4 24
$1.1B
$389.0M
Q3 24
$1.1B
$351.5M
Q2 24
$1.0B
$306.6M
Q1 24
$997.1M
$295.5M
Debt / Equity
FROG
FROG
HROW
HROW
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FROG
FROG
HROW
HROW
Operating Cash FlowLast quarter
$50.7M
$8.4M
Free Cash FlowOCF − Capex
$49.9M
$8.1M
FCF MarginFCF / Revenue
34.3%
9.1%
Capex IntensityCapex / Revenue
0.6%
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FROG
FROG
HROW
HROW
Q4 25
$50.7M
$8.4M
Q3 25
$30.2M
$16.6M
Q2 25
$36.1M
$-803.0K
Q1 25
$28.8M
$19.7M
Q4 24
$49.1M
$-17.8M
Q3 24
$27.6M
$3.0M
Q2 24
$16.7M
$-2.7M
Q1 24
$17.5M
$-4.6M
Free Cash Flow
FROG
FROG
HROW
HROW
Q4 25
$49.9M
$8.1M
Q3 25
$28.8M
$16.4M
Q2 25
$35.5M
$-969.0K
Q1 25
$28.1M
$19.5M
Q4 24
$48.5M
$-18.3M
Q3 24
$26.7M
$2.3M
Q2 24
$16.0M
$-3.1M
Q1 24
$16.6M
$-4.7M
FCF Margin
FROG
FROG
HROW
HROW
Q4 25
34.3%
9.1%
Q3 25
21.0%
22.9%
Q2 25
27.9%
-1.5%
Q1 25
23.0%
40.8%
Q4 24
41.8%
-27.4%
Q3 24
24.5%
4.8%
Q2 24
15.5%
-6.3%
Q1 24
16.6%
-13.6%
Capex Intensity
FROG
FROG
HROW
HROW
Q4 25
0.6%
0.4%
Q3 25
1.0%
0.3%
Q2 25
0.5%
0.3%
Q1 25
0.5%
0.4%
Q4 24
0.5%
0.8%
Q3 24
0.9%
1.2%
Q2 24
0.7%
0.7%
Q1 24
0.8%
0.3%
Cash Conversion
FROG
FROG
HROW
HROW
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons